Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dr Matthew Plunkett joins iPierian

This article was originally published in Scrip

Executive Summary

The US biopharmaceutical company iPierian has appointed Dr Matthew Plunkett vice-president and chief financial officer. Dr Plunkett spent the past nine years at Oppenheimer & Co, most recently as managing director where he lead the firm's biotechnology investment banking practice for the West Coast. Before that, he worked as a research scientist at Sunesis Pharmaceuticals and at Axys Advanced Technologies.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC004336

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel